Rivus Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2022
Total raised
- $167M
Investors
- 6
About Rivus Pharmaceuticals
Founded in 2019 and based in Virginia, US, Rivus Pharmaceuticals, Inc. operates as a biopharmaceutical company for cardio-metabolic health. In September 2022, Rivus Pharmaceuticals, Inc. Rivus Pharmaceuticals, Inc. provides a small molecule therapy, HU6, which is a controlled metabolic accelerator (CMA) that addresses the underlying cause of cardio-metabolic disease by harnessing the body's natural processes to improve cellular metabolism.
Who invested in Rivus Pharmaceuticals
6 investors across 2 rounds
See all investors in Rivus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rivus Pharmaceuticals
Who invested in Rivus Pharmaceuticals?
Rivus Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rivus Pharmaceuticals last raise money?
Rivus Pharmaceuticals's most recent round on record is a Series B, in Sep 2022.
What does Rivus Pharmaceuticals do?
Founded in 2019 and based in Virginia, US, Rivus Pharmaceuticals, Inc.
Where is Rivus Pharmaceuticals headquartered?
Rivus Pharmaceuticals is headquartered in Charlottesville, US.
Which VCs invest in companies like Rivus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rivus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rivus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.